N E W S L E T T E R

A N E W S L E T T E R F O R T H E C A N A D I A N P O D I A T R I C M E D I C A L A S S O C I A T I O N

REMEMBERINGA pioneer, Conn Wagner

SPECIAL OLYMPICSLearn more about this fabulous program

WEEKEND RUN TO CURE CANCERExtraordinary people who touched our hearts

PRESIDENTCPMA President addresses 2011 House of Delegates

spring 2011

P2Page 2

P14Page 4Page 3

P8Page 2

P10

2

I’m sure many of you either read or heard about a reference to Ontario Doctors of Podiatric Medicine as a “sunset” profession in the CFPM President’s message in their Fall 2010 publication. Although it was very unflattering to Ontario podiatrists, it was also rather amusing to think that someone could be so mistaken.

CPMA members across Canada are leading the way to improved podiatric medicine and Ontario’s Doctors of Podiatric Medicine are certainly part of this initiative. The scope of practice continues to grow and the need for highly trained foot and ankle practitioners is higher than ever. Add to that the requirement for podiatrists to work in a diverse range of settings, and its readily apparent that there is a greater opportunity for Canadians to get the foot care prevention and treatment they needto keep them mobile.

The Ontario Podiatric Medical Association is making significant strides towards improved levels of podiatric medicine and has the full support of the Canadian Podiatric Medical Association.

I encourage all CPMA members to practice to the highest level of care, enroll in ongo-ing continuing medical education programs and promote the profession of podiatry in your community. The CPMA is the sunrise profession and leads the way in Canada for foot and ankle care.

Joseph Stern, DPMCPMA President

CPMA members moving the profession forward

CPMA President’s messageIt’s been a busy start to 2011 for the CPMA executive. In addition to gaining a better understanding about the workings of the CPMA, we have been strategizing our goals for our first year.

Student membership is one of our key initiatives. Most professional associations have a student compo-nent within their membership categories, and that is something that the CPMA executive believe should be in place for our association too. As a result, we have been working with the director of the podiatric medicine program at the University of Quebéc at Trois Rivieres and the president of their student associa-tion. I am pleased to report that they are also enthusiastic about this initiative.

One of the most pressing issues for members relates to insurance. As you are probably aware, several insurance companies have been making changes without consultation on different aspects of services that podiatrists provide for patients. The RCMP has changed their guidelines for podiatric services and we are in dialogue with them. This month, another insurance carrier representing a large Canadian corpora-tion has implemented new rules regarding preferred providers for orthotics and orthopedic shoes. A few podiatrists are on the list, but most CPMA members are not. We have contacted the insurance carrier to get clarification on how this happened and what we need to do to have all CPMA members listed as pro-viders. These issues can affect a patient’s ability to receive the best foot care. The CPMA executive and insurance committee have made it a priority to rectify this issue.

When the new executive was elected in November 2011, we discussed ways that the CPMA could produce greater results and also encourage more involvement from our members. One of the results was to create committees for some of the important components of the CPMA, namely Communication, Insurance, Narcotics, Bylaws and Seal of Approval. CPMA board members were mandated with committee responsibilities, including populating their committee with CPMA members. I am pleased to say that all five committees have been hard at work and will be providing regular updates to our members, either through our newsletter or through email blasts. This issue provides an update from the Narcotics Committee (see page 16).

Your CPMA board is also working on creating or enhancing a number of effective partnerships. One example is the Canadian Diabetes Association and its new campaign, “Get Checked Now”, which is focused on the 40 and up age group. British Columbia podiatrist Dr. Tim Kalla has been selected as the media spokesperson for the CDA. Another example is our collaboration with Special Olympics. The CPMA and its members have been participating in the Health Feet “Fit Feet” program across Canada for several years. Dr. Kel Sherkin, from Ontario, is the current director of our “Fit Feet” program and has been instrumental in building the program across Canada. (For more information about “Fit Feet”, read his article on page 8.)

Most importantly, the CPMA board is working to ensure a healthy and vibrant association that is there for its members. I encourage you to get in touch with any of the CPMA board to discuss issues, concerns or ideas you may have.

Board Contact Information

HOW TO GET INVOLVED

President: Dr. Joseph STERN – cpmapresident@podiatrycanada.orgTreasurer: Dr. Brad SONNEMA – cpmatreasurer@podiatrycanada.orgSecretary: Dr. Richard BOCHINSKI – cpmasecretary@podiatrycanada.orgPast President: Dr. Mario TURANOVIC – mgtdpm@telusplanet.netExecutive Director: Jayne JENEROUX – cpmaed@podiatrycanada.org

Provincial board representatives:British Columbia: Dr. Greg LAAKMANN – e-footdoc@telus.netAlberta: Dr. Mario TURANOVIC – mgtdpm@telusplanet.netManitoba: Dr. Alicia SNIDER – ajsnider@mymts.netOntario: Dr. Bruce RAMSDEN – bramsden@rogers.comQuebec: Dr. Genevieve PAYETTE – genpay@hotmail.com

President Dr. Joseph Stern

REMEMBERING A PODIATRY PIONEER

After serving the Canadian Forces in World War II, Dr. Wagner along with Drs. Hardy, Hewitt, Pozer and a few others went to podiatry school in Chicago, Illinois under the auspices of the Veterans Bill which was designed to educate, upgrade and train veterans for integration into society at that time.

Drs. Wagner, Hewitt, Phelps and Pozer practiced in the old Woodward’s Building on Hastings Street. Woodward’s at that time was the central meeting place of the City of Vancouver and a stone’s throw to the prac-tice and business of Dr. Pierre Paris (the father of two generations of podiatrists). As times changed, so did the practice at Woodward’s. Eventually, Dr. Wagner moved to the upscale West Vancouver, Dr. Phelps moved to Kerrisdale and Drs. Pozer and Hewitt established their clinic in Kitsilano.

In the late 1950s a free Podiatry Clinic was established at the Outpatients Department (OPD) of Vancouver General Hospital. This clinic was manned for years on a volunteer basis by Drs. Hardy, Hewitt, Hilliard, Mathews, Paris and Wagner. The Podiatry Clinic was the most popular clinic at the OPD with long line ups. It also fostered goodwill with Vancouver General Hospital and the medical community. It also served as the seed for developing the first and for a long time the only podiatric residency program in Canada. Dr. Wagner was instru-mental, along with his colleagues, in obtaining accredita-tion of the podiatric residency program.

Dr. Wagner led the fold. He was visionary and had the foresight to model foot care in British Columbia towards podiatry. In the late 1950s he was instrumental in chang-ing the title of the profession from chiropody to podiatry even though it meant sacrificing quality time with his family to take the necessary upgrading courses and qualifying examinations.

Dr. Wagner was active in lobbying the law makers. As part of the Legislative Committee, Drs. Wagner, Hewitt, Hardy, Hilliard, Mathews and Virgil were instrumental in the formulation of the BC Podiatry Act which is the

basis for the current Act. They were able to include in the definition of “practitioner” in the Pharmacists Act: “a person authorized under the law… to practice medicine, dentistry, podiatry or veterinary medicine”. Podiatrists were amongst the first to be granted the right to use the title “Dr.” after considerable lobbying.

Over the years, Dr. Wagner served on a volunteer basis in all capacities of the Executive Council of British Columbia Association of Podiatrists – from Councilor, Treasurer, Secretary, to President. He served as chair person in many committees. To cite a few examples: Dr. Wagner worked in the committee to have podiatry included as a provider in the BC Medical Services Plan (MSP). BCMSP not only covered routine podiatry care but surgical/procedural fees. These surgical fee items to this date still exits. Dr. Wagner singlehandedly repre-sented British Columbia in International Region 7 from its inception for many years. Dr. Wagner and Norma (his wife) hosted many executive meetings and brainstorm-ing sessions at his oceanfront home in West Vancouver.

In 1993 Dr. Wagner retired from his practice in West Vancouver and moved to Abbotsford, B.C. In his retire-ment, he was still active in Church ensuring the refu-gees sponsored into Canada integrate into the Canadian society and culture. He maintained leadership roles throughout retirement in several support groups. He will be missed by his friends and colleagues, but most of all, by Norma his wife and Ruth his daughter. His perpetual, sincere smile will also be missed.

DR. CON WAGNER, D.P.M. (1924 – 2011)

Dr. Conrad Ervin Wagner of Abbotsford, B.C. passed away on February 4, 2011 succumbing to cancer.

PHARMACISTS ACT

“pharmacy” means a place where drugs may be dis-pensed, stored or sold to the public;

“practitioner” means a person authorized under the law of any province to practise medicine, dentistry, podiatry or veterinary medicine;

“prescription” means a direc-tion from a practitioner that a specified amount of a speci-fied drug be dispensed;

“registrar” means the regis-trar of the college appointed by the council and includes a deputy registrar;

“respondent” means a person notified by citation under section 34;

“rules” means the rules of the college prescribed by the council;

September 1980

3

4

If you think you may be one of them, we can help youget checked now.

Learn more at getcheckednow.ca

1-800-BANTING (226-8464)

Thanks to our campaign sponsors

Today, a million Canadians have type 2 diabetes and have no idea.

Fullpage_GCN_Dialogue_Feb23.indd 1 2/24/11 10:34 AM

5

“Get Checked Now” launched on March 1, 2011, along with the Association’s collaboration with Loblaw Companies Ltd., a national retailer that will be sup-porting the campaign through the “Get Checked Now” program by offering complimentary diabetes risk assessments and educations resources at hun-dreds of their in-store pharmacies. According to a recent Environics public opinion poll commissioned by the Association, 43% of Canadians (people without diabetes) have never been tested for type 2 diabetes. “Diabetes has reached epidemic proportions,” says Michael Cloutier, president and CEO of the Association. “But many people with prediabetes or undiag-nosed type 2 diabetes may actually display no symptoms. That’s why it is criti-cal that we all act now, as diabetes is not only costing our healthcare system, but is costing Canadians their lives.”

The “Get Checked Now” campaign highlights one of the more dramatic signs that someone is living with undiagnosed type 2 diabetes may experience – severe tingling or numbness in the extremities known as diabetic peripheral neuropathy.

Greg Laakmann, president of the BC Podiatric Medical Association (formerly the BC Association of Podiatrists) said in a recent statement, “Our association applauds the Canadian Diabetes Association’s efforts in raising awareness of diabetes and how it can detrimentally affect those that have the disease, whether they know it or not. As our profession deals primarily with the foot, the area of diabetic peripheral neuropathy plays an especially important role in our patients, both current and future ones.” A television and radio public service announcement has been urging Canadians to visit the getcheckednow.ca website where individuals who think they may be at risk can find more information and, most importantly, find out where they can get checked. You can get checked now at hundreds of

participating Loblaw and Drugstore pharmacies located at Loblaws, Zehrs, Extra Foods, Atlantic Superstores, Real Canadian Superstores and Your Independent Grocers. Beginning in April at select retail pharmacy locations, Loblaw and the Association will also be providing hundreds of unique diabetes education sessions to help Canadians learn how to better manage their diabe-tes and live healthy lives.

Visit getcheckednow.ca to find out more information about the campaign and to locate a participating pharmacy

in your community.

THE CANADIAN DIABETES ASSOCIATION HAS BEGUN A NATIONAL PUBLIC AWARENESS CAMPAIGN AIMED AT CANADIANS 40 AND OLDER, ALERTING THEM TO THE CONSEQUENCES OF BEING PASSIVE ABOUT TYPE 2 DIABETES AND LEADING THEM TO TAKE URGENT ACTION BY GETTING CHECKED FOR THE DISEASE.

“Get Checked Now” campaign launched to help combat type 2 diabetes

Where to find: customerservice@mcg-ae.com 1-800-251-9586

6

To register, make hotel reservations, and get more information, visit

www.apma.org/thenational.

Opening SeSSiOn Featuring Ross Shafer, six-time Emmy Award-winning comedian, writer and TV host

Schedule at-a-Glance

WedneSday, July 27, 2011

8:30 am – Noon Surgical Workshop 1 1:00 – 4:30 pm Surgical Workshop 2 2:00 – 6:00 pm APMA Registration

thurSday, July 28, 2011

7:00 am – 6:30 pm APMA Registration7:30 – 9:00 am Breakfast Symposium9:00 – 10:00 am Plenary Lecture 10:00 am – 3:00 pm Scientific Sessions12:00 – 1:00 pm Podiatry Management’s Hall of Fame Luncheon3:00 – 4:00 pm Opening Session Address4:00 – 6:30 pm Exhibit Hall Grand Opening

Friday, July 29, 2011

7:00 am – 5:00 pm APMA Registration7:30 – 9:00 am Breakfast Symposium9:00 – 10:00 am Plenary Lecture9:00 am – 5:00 pm Exhibit Hall Open10:30 am – 5:00 pm Scientific Sessions5:00 – 6:00 pm Poster Abstracts Reception

Saturday, July 30, 2011

7:00 am – 5:00 pm APMA Registration7:30 – 9:00 am Breakfast Symposium (non-CME)9:00 – 10:00 am Plenary Lecture9:00 am – Noon Surgical Workshop 39:00 am – 1:30 pm Exhibit Hall Open10:30 am – 3:00 pm Scientific Sessions12:30 – 3:30 pm Surgical Workshop 43:30 – 5:30 pm PICA Risk Management Program6:00 – 7:30 pm APMA Final Night Reception

Sunday, July 31, 2011

7:00 – 10:00 am APMA Registration7:30 – 9:00 am Breakfast Symposium9:30 am – Noon Scientific Sessions

hOSt hOtelSingle/Double: $230 (through June 23, 2011)

Single/Double: $230

(through July 5, 2011)

reGiStratiOn APMA MEMBERS SAvE $300! Early-bird registration available now through March 31, 2011. Podiatric medical students and APMA postgraduate members receive complimentary registration.

Make your hotel reservation today; the APMA room blocks are limited. Once the blocks are full, rooms are subject to availability at prevailing rates.

assistant discountEach additional Assistant from the same APMA Member practice receives a 25% discount. Enter discount code ASST25.

7

It’s always a learning curve working with new people, but it’s always interesting too. With a new executive for the CPMA, I am quickly adapting to their preferred forms of communication (email versus phone discussions for some and the reverse for others).

I think the CPMA has a great new executive who are very interested in making change happen. In addition to key pri-orities that Dr. Joseph Stern identified in his message on pg 2, another emphasis of the new executive is more com-munication.

Establishing a Commun-ications Committee is a new start, which will allow us to not only provide more frequent communication but to also create different

avenues of communication. We have recently completed a communications plan and will start rolling out some of the initiatives identified in it, such as monthly eblasts to CPMA members and addi-tional features on the CPMA website. As mentioned in my last update, we now have a secured member section. All CPMA members are encour-aged to log on to the CPMA website at www.podiatry-canada.org to obtain their password so that they have access to the information available on the members only section.

The CPMA will once again be attending the CLHIA Annual Conference, and it’s inter-esting that new people are wanting to participate in this opportunity.

The more CPMA members we get involved in various activities of the organization the more we can collectively do for our members. There are so many ways to get involved. You can participate on a committee, volunteer to work with either a local, provincial or national event or just submit ideas and sugges-tions – all forms of participa-tion are valuable, and help improve the value and reach of the CPMA.

Jayne Jeneroux CPMA Executive Director

Executive Director’s Update

would like to wish the

a Happy 87th Birthday!To celebrate the occasion we are

pleased to extend to all the CPMA members a *10% discount

on polymer gel products!*Please quote the discount code

when ordering: CPMA 04511

Offer valid April 15th through May 31st, 2011.

Not available on already discounted items.

New Products available April 2011

# 1251 Medium 12/pkg# 1252 Large 12/pkg

# 1251-2 Medium 4/pkg# 1252-2 Large 4/pkg

# 1208 One Size 6/pkg # 1208-2 One Size1/pkg

All Gel Toe Spreader with Toe Loop

All Gel Bunion with Spreader

Soft �exible gel loop maintains proper toe alignment. Reduces friction/irritation and provides relief on the bunion joint. Designed to wear in most shoes.

Eases bunion pain and provides proper toe alignment. Reduces pressure on MP joint. Patented design provides protection between the Hallux toe and shoe. Product easily slips over the Hallux toe. Designed to wear in most shoes.

5-18 JF Kennedy, St-Jérome, Qc J7Y 4B6 T: (800) 547-4767 F: (888) 638-1525

§

CALL US TOLL FREE @1 (800) 547-4767

NEW!

NEW!

WOW!10% OFF

WE ARE CONSIDERING ADDING A DISCUSSION FORUM ON THE WEB-SITE, AND WOULD LIKE TO HEAR FROM YOU ABOUT THIS IDEA.

DO YOU WANT A DISCUSSION FORUM? IF SO, WHAT AREAS OF DISCUSSION WOULD YOU LIKE TO SEE?

SEND YOUR COMMENTS TO CPMAED@PODIATRYCANADA.ORG

International Region 7 Annual Conference

The Region VII APMA 2011 Meeting will take place at The Sheraton Wall Centre, November 11-13 in Vancouver, British Columbia

For more information about the conference, please visit www.foothealth.ca or www.region7apma.org/annualmeeting.html

12345

Special Olympics is a grass-roots movement on a global basis, with more than two million athletes and over 150 countries involved. The Special Olympics involves athletes who have intellectual disabilities (ID) and are tested showing an IQ of 90 or less. Some of these athletes are also physically challenged. It has been estimated that close to 20% of all Special Olympians are afflicted with Down’s Syndrome. To quote from the Handbook for the Special Olympic Movement, “competition and training, not recreation, is the cornerstone for Special Olympics’ unique model of competition. Athletes of all skill levels with Intellectual Disabilities are welcome to participate in Special Olympics”.

Special Olympics began in 1968 when Eunice Kennedy Shriver orga-nized the First International Special Olympics Games in Soldier Field, Chicago, Illinois, USA. The concept was born in the early 1960s when Mrs. Shriver started a camp for people with ID.

The start of Healthy Athletes occurred after Steve Perlman, DDS, saw Rosemary Kennedy, Eunice’s daughter, in an attempt to salvage her teeth. Rosemary was born with ID. At that time, the recommenda-tion was for a frontal lobotomy! She was living in a group home in Minnesota, and was not receiving the proper dental care, irrespective of her family’s financial ability to pay for the much needed dental treatment. Upon the completion of treatment for Rosemary, Dr. Perlman was challenged to improve health care in patients with ID. Thus Healthy Athletes was born in 1966.

Persons with intellectual and devel-opment disabilities (I/DD) have a 40% greater risk of preventable secondary health conditions such as obesity, poor fitness, nutritional deficits, untreated or poorly treated vision, dental, hearing and podi-atric problems. These disparities in health care result from a lack of access and ability to pay for servic-es, poor knowledge of practitioners and poorly developed and supported

behaviours to promote health.

The Healthy Athletes Special Olympics programme was designed specifically to address and redress these issues. Health care professionals and stu-dents are enlisted and trained to provide the screenings and education to these athletes.

These health care professionals also educate the professional community about the health needs and abilities of persons with I/DD.

Presently there are seven disciplines that provide the screenings at the various athletic events:

Opening Eyes – initiated in 1991. Optometrists provide visual screen-ings. Lions Club International raises over $10 million annually for the sole purpose of providing prescrip-tion eyewear to the athletes at the various games.

Special Smiles – initiated in 1993. The dental community provides the athletes with a much-needed oral assessment.

FUNfitness – initiated in 1999. Physiotherapists evaluate the overall strength, balance and flexibility of the athletes.

Healthy Hearing – initiated in 2000. Audiologists evaluate the hearing and, if needed, provide custom swim plugs for the athletes.

Health Promotion – initiated in 2000. Nutritionists focus on nutri-tion, hydration, tobacco avoidance and bone health. They also empower the athletes to make life style chang-es that will improve their long-term health.

continued on page 9

To provide year-round sport training and athletic competition in a variety of Olympic-type sports for individu-als with intellectual disabilities by giving them continuing opportunities to develop physical fitness, demon-strate courage, experience joy and participate in a sharing of gifts, skills, and friendship with their families, other Special Olympics athletes and the community.

The first World Games were in Chicago and were attended by two countries – Canada and the USA.

The mission of Special Olympics is to provide year-round sports training and athletic competi-tion in a variety of Olympic-type sports for children and adults with intellectual disabilities, giv-ing them continuing opportuni-ties to develop physical fitness, demonstrate courage, experi-ence joy and participate in a sharing of gifts, skills and friend-ship with their families, other Special Olympics athletes and the community.

MISSION STATEMENT

DID YOU KNOW...

Special Olympics Oath taken by Special

Olympics athletes: Let me win, but if I cannot win, let me be brave in the attempt.

The story behind Special Olympics and its Healthy Athletes program

Acknowledgement is given to Special Olympics International for providing the background information.

8

9

6 7continued from page 8Fit Feet – initiated in 2003. Podiatrists evaluate the skin, nails, bones and joints of the feet. Socks and shoes are also inspected and a general gait assessment is performed.

I introduced the Fit Feet programme to Canada in 2006, starting first in Ontario and then eventually across Canada.

Each province has a Provincial Fit Feet director who is responsible for organizing and running the screen-ing programme when their province holds a Special Olympics event. Generally, these events take place once or twice a year. The director enlists the support and volunteerism of local and provincial podiatrists. In most cases, the events take place on a Saturday

and/or a Sunday, therefore the time that the podia-trists offer their help generally does not affect their office time.

MedFest – initiated in 2009. Medical doctors provide and complete physical examinations of the athletes. This discipline was introduced in Canada in 2011 for the first time at the Ontario Provincial Winter Games in Thunder Bay.

I encourage all of my colleagues to get involved with the Special Olympics Healthy Athletes programme. It is a very worthy and fulfilling experience, and your involvement becomes a win-win situation. You win by knowing that you are helping athletes with ID to get much-needed foot evaluations and possibly future treatment. Athletes win by being given a first-rate

podiatric examination, possibly for the first time. With the knowledge that these athletes get from you, they will then be able to continue to compete and maintain a relatively healthy life.

I am always looking for volunteers. Contact me through the CPMA if you want to get involved.

Kel Sherkin, DPMCanadian Director Fit Feet Healthy Athletes Special Olympics

Amplify the JoyStay active...WEAR WIGWAM® socks.

check out all our health socks at: www.wigwam.com

Canada’s best selling health sock!

The Simcan Comfort Sock® is Canada’s best selling health sock for a reason.

Simcan’s ergonomically designed socks are created to accommodate your patients most sensitive foot issues.

Our low investment sock display takes up very little space yet yields a strong return to your bottom line.

It’s a two square foot powerhouse profit centre that provides total customer satisfaction.

Call: 1-877-255-6755

www.simcan.net

On August 28, 2010, despite humid, 30+ Celsius degree weather, a handful of brave podiatric medicine students from the Université du Québec à Trois-Rivières (UQTR), along with volunteer podiatrists, were determined to be part of an event that is dear to their hearts – the 6th edition of the Montreal Jewish General Hospital Weekend to End Breast Cancer. It is a fundraiser where over 2250 people walked and raised $5.1 million to fund research against breast cancer and other femi-nine cancers that cost so many pre-cious lives.

The 60 km walk was held in Montreal and lasted through the weekend of

August 28th and 29th. Tents were set up by the hospital’s organization com-mittee in a park to accommodate the participants who slept at the Queen of Angel’s academy, Dorval, on Saturday evening. During the day, walkers were cheered by many supporters and many halts were set up, which pro-vided refreshments, food and, most importantly, medical support to help alleviate the pain that many walkers had to endure as their feet were sore. We, the podiatric team, under the supervision of Doctors Bluma Girzon and Charles Faucher, were ready with gauze, plasters, scissors and enthusiasm to enable many walkers to pursue their long-awaited trek. The hot weather combined with shoes that were not always a perfect fit resulted in many blisters that we had to treat on the spot. Not to mention toe nails that

needed attention, shoes that were too small, as well as muscular and liga-mentary pain that required taping or massaging. As we cared for our many patients, we met persevering, dedi-cated people with admirable will. Who would have believed that the podiatric treatment tent would have been so popular!!! In spite of a long lineup, par-ticipants were patient and showed a lot of recognition towards us, volunteers.On top of caring for patients, this experience allowed us to meet extraor-dinary people whose stories touched our hearts. These people, walking for the cause, are either cancer survivors, people currently fighting the disease or friends or relatives of people affected

or deceased because of cancer. They all have one thing in common – their engagement to walk 60 km to help find a cure for feminine cancers.

In addition to giving us a lot of visibil-ity, this event supported a very good cause. As podiatrists, we should all participate in a lot of public events and fundraising causes so we can promote the profession. Even if the event is held just over a weekend, you will remember it for the rest of your life by meeting remarkable people and learn-ing a lot. Personally, being part of the Weekend to End Breast Cancer really inspired us to make changes in society and we surely will pursue this tradi-tion in 2011. Let’s walk hand in hand, step by step, to get closer to a cure for feminine cancers!

by Marie-Christine Bergeron (volunteer 2009, 2010) and Gabrielle L’Écuyer Lapierre (volunteer 2010) Podiatric Medicine students at Université du Québec à Trois-Rivières.

Event participation well worth the effort

Proud Walkers

Marie-Christine Bergeron and Magali Paquet-Laroche, volunteers

Marie-Christine Bergeron, Marie-Claude Charest et Gabrielle L’Écuyer Lapierre, volunteers

“Who would have believed that the podiatric treat-ment tent would have been so popular!

11

A historic change took place on February 1, 2011 here in BC as the podiatry profession underwent a significant legislative transformation. On that day, the old, antiquated BC Association of Podiatrists and the Board of Examiners in Podiatry ceased to exist as the Podiatrists Act was officially repealed. In its place, a new College of Podiatric Surgeons of BC (CPSBC) was created under the Health Professions Act and a new BC Podiatric Medical Association (BCPMA) was created under the Society Act.

The CPSBC becomes the public body responsible for governing the profession of podiatry in BC and protecting the public. Specifically, the CPSBC will handle issues related to registration, inquiry, discipline, quality assurance, surgical practice standards and patient relations. The scope of

practice for podiatry has been expanded to not only include the foot but also the structures of the lower leg (that govern the function of the foot). For more information, visit the CPSBC website at www.bcpodiatrists.org. The old BCAP phone number now serves as the CPSBC phone number which is 604-602-0400.

In contrast, the BCPMA becomes the body dedi-cated to promoting the profession of podiatry and providing assistance and benefits to its members. This will include organizing seminars and provid-ing opportunities for CME credits. The BCPMA will continue to maintain close ties with the CPMA and be involved with helping to further its interests here in BC. Additional information can be found at www.foothealth.ca.

This year’s annual BCPMA seminar is being held at the Sheraton Wall Centre Hotel in Vancouver, BC from November 11th - 13th, 2011. The seminar will be held in conjunction with the APMA Region VII Seminar and be combined with the Live Well with Diabetes Seminar to provide a truly balanced yet diversified series of lectures with ample CME cred-its. Please visit the BCPMA website for updates and information on registration or call the BCPMA at 604-682-2767.

Fraternally,Greg Laakmann, DPM, FACFASPresident, BCPMA

PROVINCIAL UPDATES

British Columbia

Despite the continued snow storms and very cold temperatures that Alberta has experienced all win-ter, the Alberta Podiatry Association continues to move forward with its preparations to come into the Health Professions Act (HPA). The APA Executive recently met with Alberta Health to ensure that the steps being taken are in alignment with the HPA requirements. We expect to have our bylaws com-pleted in the next few months.

The APA has also finished all aspects of the Foreign Qualifications Review (FQR) project that was funded by Alberta Employment and Immigration and has now been completed. This

project was designed to explore the role of foot practitioners from other countries and how their qualifications compared against the qualifications for podiatrists set out in the APA bylaws. While the current Alberta Podiatry Act does not allow for any classifications of foot practitioners, other than Doctor of Podiatric Medicine, under the HPA there is an opportunity to establish other categories. Materials created through the project are posted on the APA website at www.albertapodiatry.com

The APA will soon be embarking on another government-funded initiative. Starting April 1, 2011, the Occupational Health and Safety project will get

underway. The purpose of this project is to create greater awareness among Alberta podiatrists about occupational health and safety risks and preventa-tive measures that can be taken. It is anticipated that educational materials will be created and dis-tributed and shared with APA members. The APA is more than happy to also share these materials with CPMA members when they are completed.

Mario G. Turanovic, DPMPresident, Alberta Podiatry Association

Alberta

12

The Manitoba Podiatry Association has been work-ing on its new web page and is in the final stages of having it up and running. Our executive mem-bership changed at the last AGM and this put a slight delay to the web page as ideas from the new executive were addressed.

Liaising with Manitoba Blue Cross is ongoing and we will be setting up meetings with other extended health benefit groups to strengthen our relation-ships.

Our agenda for 2011 is to provide continuing pro-fessional development (CPD) opportunities, CPR

and better rates for malpractice. We are currently on the second draft of the revised bylaws and will be presenting them at the AGM for approval. Alicia SniderPresident, Manitoba Podiatry Association

Manitoba

Quebec

This year will be another busy year. At the begin-ning of April 2011, L’Ordre des Podiatres du Québec will hold an election to name a new presi-dent. Two candidates are in contention.

In May, L’Ordre will meet with podologues from France to work on the Québec-France agree-ment. And in June, 20 new podiatrists will graduate from the Université of Québec in Trois-Rivières. Québec will also be hosting the 2012

CPMA AGM. Both the city location and exact dates will be determined in the near future.

Genevieve Payette, DPM, CPMA representativeOrdre des Podiatres du Québec

The Easier, Cleaner, Faster Way to take 3D impressions of your patient’s feet

VeriScan

Podiatric Scanner

Capture True Non-Weight Bearing Foot Anatomy In 3.5 Seconds

For more information on the VeriScan or to watch a demonstration of the scanner, please visit our website:

www.parisorthotics.com or contact:

customerservice@parisorthotics.com

13

©2

011

Sau

con

y, In

c.

saucony.com

WE KNOW BECAUSE

WE RUN.

©2

011

Sau

con

y, In

c.

FIND YOURSTRONG

saucony.com

WE KNOW BECAUSEWE KNOW BECAUSE

WE RUN.WE RUN.WE RUN.WE RUN.

Ontario

Ontario’s provincial budget is expect-ed to be tabled in late March or early April. As occurs every year at this time, the Ontario Podiatric Medical Association (OPMA) is preoccupied with ensuring continuation of the sta-tus quo with respect to OHIP billings. It is a source of pride to the OPMA that podiatry in Ontario is the only profession other than medicine that has not been fully or partially delisted from the Ontario Health Insurance Plan (OHIP). It is clearly a testament to the important role that podiatrists provide in Ontario’s health care delivery system. Having said that, the OPMA has notified the Ontario Ministry of Health and Long-Term Care that it wishes to modernize and clarify the OHIP podiatry fee for ser-vices schedule.

The OPMA is part of an ad hoc coalition of health care professional associations and colleges that is crystallizing around the task of mod-ernizing and clarifying the Healing Arts Radiation Protection (HARP) Act. The OPMA is also in the process of responding to a draft regulation relating to those professions that may order or perform CT scans or operate CT scanners.The review by the Health Professions Regulatory Advisory Council (HPRAC) that hopefully will result in Ontario’s conversion to a full scope podiatry model is still scheduled to begin by 2014, or when the other reviews in the pipeline have been completed, whichever comes first. The OPMA continues to support the College of Chiropodists and Podiatrists of Ontario in its efforts to bring forward the review. For the past year, HPRAC hasn’t really been operational, which is of concern to the OPMA because it decreases the like-lihood of our review being expedited.

However, in February 2011, the posi-tion of HPRAC Chair and the vacant positions on Council were filled, which means that HPRAC should be back in business fairly soon. The first items of business on the HPRAC agenda will be reviewing and updat-ing its criteria for the regulation of new professions and for scope of practice changes to existing profes-sions. The second exercise could obviously have a major impact on the podiatry/chiropody review.Several podiatrists who are registered to practice as podiatrists in another Canadian province have applied, or intend to apply, for “permit to permit” registration as podiatrists in Ontario under the Agreement on Internal Trade. Although not directly involved, we are watching this closely to see how the College and Ontario manage to square their requirements under the AIT with the legislative podiatric cap that persists in Ontario.

Bruce Ramsden, DPMPresident, Ontario Podiatric Medical Association

14

Dear Mr. Speaker, Mr. President, Board of Trustees, APMA members, staff and officers. Thank you for the opportunity to speak to your 2011 House of Delegates.

As the new president of the Canadian Podiatric Medical Association, this is my first opportunity to attend these meetings and to meet with many of you. It is indeed an honour to stand before you and share information about the podiatry profession in Canada. I must give credit to my pre-decessors – Drs. Robert Chelin and Mario Turanovic, past presidents of the CPMA – for helping to pave the way and make it possible for me to be here today.

I was elected as President of the CPMA last November, along with a new executive board. Our new dynamic and energetic board Is focused on creating new oppor-tunities for our members. During my presi-dency, it is my mission and mandate to unify our profession in Canada. To achieve that success and to be an effective leader, it is imperative that one must listen to its membership and communicate on a regular basis. To do so, I will make it my mandate to visit all our provincial partners over my term.

As Colin Powell has said, “there are no secrets to success. It is the result of preparation, hard work and learning from failure.”

The CPMA continues to grow its member-ship from coast to coast and its success has been due to our increase in our member benefits, but to do so comes at a price. Thanks to the collaboration of the New York College of Podiatric Medicine and the University of Québec at Trois Rivieres, our one and only podiatry school, we now have a steady stream of podiatric students that are being trained in Canada. This May, we will see the fourth graduat-ing class of podiatrists ready to practice in Quebec.

It truly is an exciting time for podiatry in

our country. We are making significant progress on issues that have been under-way for some time. One of our key issues is podiatry’s inclusion in prescribing rights for narcotics. The CPMA has been lob-bying the federal government about full narcotics prescribing privileges for our members. I’m very pleased to say that we are now very, very close to having this ini-tiative completed within 12-18 months.

As well, our two most western provinces are making changes in relation to the Health Professions Act in British Columbia and Alberta. The Health Professions Act is provincial legislation in each province to govern all regulated health profes-sions under one umbrella. Key features of this legislation include self-regulation, transparency to the public, protected titles, restricted activities and continuing competency. B.C. came into the act on February 1, 2011 and is now busy setting up committees; Alberta’s regulations are near completion, and they are awaiting Order in Council approval before it comes into the Act.

While western Canada leads the way for podiatric medicine in Canada, there is also movement happening in other provinces. For example, Ontario continues to push for removal of the cap on DPMs. Manitoba and Saskatchewan have included “Doctor of Podiatric Medicine” in their legislation, which will enable qualified practitioners to undertake the full DPM scope of practice.

When we look at podiatry in the United States and Canada, there are many simi-larities in terms of practice parity between our two countries. In fact, 95% of the CPMA members are graduates of the United States podiatry schools and have residency training.

Much like the APMA, the CPMA works with various related organizations. One example is our involvement with the Canadian Diabetes Association and its new campaign “get checked now”, which

is focused at the 40 and up age group. In fact, British Columbia podiatrist, Dr. Tim Kalla, has been selected as a media spokesperson for the CDA.

Another example is our collaboration with Special Olympics. The CPMA and its members have been participating in “Fit Feet” programs across Canada for several years. Dr. Kel Sherkin is the Canadian director of our Fit Feet: program, and is the individual who engineered podiatry’s involvement in Special Olympics.

While the specifics of podiatric medicine do vary somewhat across Canada, we are all focused on providing the best foot and ankle care for our patients.

By working together with the APMA, we provide the opportunity for all of our col-lective members to continue their lifelong learning and enhance the podiatry profes-sion. The friendship protocol that was established between the APMA and the CPMA has helped to flourish podiatry in Canada. Many of our members take part in your annual scientific seminars, and American podiatrists also take part in sci-entific seminars held in Canada. This year, the Region VII conference will be held in November in Vancouver, British Columbia, November 11-13, and two podiatrists from the American Society of Podiatric Surgery will be on the program.

The CPMA Annual General Meeting will take place in Toronto, Ontario September 15-17 and I hope that I will have the

opportunity to host the new CPMA President, Mike King.

I thank you for the opportunity to speak before you today and I look forward to continued opportunities to meet and learn from each other. I would like to con-gratulate Dr. Stone on her presidency and would also like to wish Dr. King and the APMA Board much success.

I’d like to ask Dr. Stone to join me on the podium. … Dr. Stone, on behalf of the CPMA, I’d like to thank you for your tremendous support and interest you’ve provided us over your term. I hope our paths cross in the future. As a token of our appreciation, I’d like to present you with this West Coast Indian Art letter opener from Victoria, British Columbia.

I’d also like to ask Dr. King to join me on the podium. … Dr. King, in preparation for your presidency, I would like to present you with this gift. I know you are a base-ball fan as much as I am a hockey fan. So for those times your team is not winning or you have the presidency blues, here’s a bottle of ice wine from the great white north to soothe those evenings.

As President of the CPMA, I look forward to working with you in continuing our friendship protocol and exchange of ideas to better our profession.

On behalf of the CPMA Executive Director, Jayne Jeneroux, and myself, I thank you for your hospitality, support and friendship.

On March 20, 2011, Dr. Joseph Stern addressed the 2011 House of Delegates of the American Podiatric Medical Association (APMA). Provide below is the speech he gave.

CPMA President addresses the 2011 APMA House of Delegates

From left to right: Professor Stuart Baird, Chairman of the Society of Chiropodists and Po-diatrists; Dr. Joseph Stern, President of the Canadian Podiatric Medical Association; Janet McInnes, President of the Federation Internationales des Podologues/International Federa-tion of Podiatrists; and Dr. Robert Chelin, Past President of the Federation Internationale des Podologues/International Federation of Podiatrists

15

Heel Kicker begins smooth forward motion

Rocker Sole smoothly rocks you forward,conserving energy and reducing fatigue

Concave Heel absorbs shock, reducing stress on joints

Toe-Offguides your foot, enhancing naturalwalking motion

Clarks_WAVE_CPMA_Ad.indd 1 11-03-14 3:56 PM

One of the components of the CPMA that generates consid-erable interest is our CPMA Seal of Acceptance/Approval program. Placing the Seal of Approval/Acceptance on prod-ucts is a very effective way for companies to promote their products to podiatrists and to the general public. Currently, the CPMA program includes the following categories:• footwear• socks• creams/gels• anklesupport

Our newest products are the Clarks Wave shoe style and

new version of the Saucony Pro Grid shoes. The CPMA website provides a listing of the various compa-nies that have the CPMA Seal of Acceptance/Approval Check it out at through the following URLs. http://www.podiatrycan-ada.org/our_sp02.html

http://www.podiatrycanada.org/our_sp03.html

http://www.podiatrycanada.org/our_sp04.html

http://www.podiatrycanada.org/our_sp06.html

Recognizing quality productsCPMA SEAL OF ACCEPTANCE/APPROVAL PROGRAM

If you haven't yetregistered on the FIP sitewww.�pnet.org take a moment to do so now.

If you have already registered, be sure to check back often for updates, contest announcements and more.

Connected yet?

www.�pnet.orgYour primary source for podiatry information around the world!

The CPMA Seal of Acceptance/Approval program consists of two components:

• SealofAcceptance–forfootwearand other products external to the foot such as equipment, hosiery and materials

• SealofApproval–fortherapeuticproducts.

The Seal is awarded to products after a careful review by a commit-

tee of expert podiatrists who have determined that the product(s) pro-mote quality foot health.

If you know of a company that may be interested in the CPMA Seal of Acceptance/Approval program, please forward information about the company to Jayne Jeneroux at jjeneroux@xplornet.com.

ABOUT THE PROGRAM

16

BACKGROUNDAs most of you are aware, the Canadian Podiatric Medical Association (CPMA) has been lobbying for narcotics prescribing privileges for several years. This update is intended to provide you with an overview of the steps taken and where the initiative cur-rently stands for podiatrists.

Meetings began in 2005 to discuss concerns among three distinct groups (podiatrists, nurse practitioners and midwives) seek-ing prescribing privileges for controlled substances. The intent was to allow these practitioners to conduct activities with con-trolled substances if they were authorized to do so under provincial/territorial legislation. After many meetings and conference calls, the proposed New Classes of Practitioners Regulations (NCPR) were originally pre- published in the Canada Gazette, Part I on June 30, 2007.

During and after the pre-publication com-ment period, provincial/territorial (P/T) minis-tries of health and stakeholder groups raised a number of concerns.

In response to the concerns, Health Canada launched a new round of dialogue with P/T health ministries in July 2009. An ad hoc federal/provincial/territorial working group was formed to resolve key concerns and develop a revised draft of the regulatory proposal. The revised proposal deletes the proposed schedules by incorporating refer-ences to the Narcotic Control Regulations (NCR), Benzodiazepines and Other Targeted Substances Regulations (BOTSR) and the Food and Drug Regulations-Part G(FDR-G), with the exclusion of:• heroin,cannabis,opium,cocaleafand

anabolic steroids• buprenorphineandmethadone

Proposed changes to the drug schedules are in sync with other regulations under the Controlled Drugs and Substances Act, ensures all practitioners are treated equally under the CDSA (with the exception of cer-tain exclusions) and provides flexibility for P/T ministries of health to establish which controlled substances should be included under the scope of practice for podiatrists.

Changes in the definition of podiatrist are also proposed – delete sections (b) and (c) in the current definition and replacing the term “Doctor of Podiatric Medicine” with “Podiatrist”. These two changes reflect ongoing work in some P/Ts regarding potential expansion of scope of practice and better reflect the range of educational back-grounds of podiatrists. Accompanying provi-sions would ensure that only podiatrists with appropriate P/T authorization can handle controlled substances.

Health Canada aims to prepare a new regulatory proposal to be submitted to the Treasury Board Secretariat by June 2011 for approval to pre-publish in Canada Gazette, Part I.

WHAT DOES THIS MEAN FOR PODIATRISTS?Essentially, Health Canada is handing over the responsibility for this issue to the prov-inces. Each provincial health department will determine who qualifies for prescribing privileges of controlled substances. This is good news, especially for provinces that have already taken the necessary steps to ensure that their province already realizes the importance of podiatrists and the need for them to prescribe certain controlled sub-stances for their patients. Alberta is one of these provinces, and is ready to make the transition as soon as the regulations are approved.

WHAT CAN PROVINCIAL PODIATRY ASSOCIATIONS DO TO GET READY?Between now and when the regulations are approved is an important time to cre-ate greater awareness about the podiatry profession in your province to ensure that people know what podiatrists are, what they do, and what their qualifications are. If you haven’t already started dialogue with practi-tioners who may be interested or concerned about podiatrists getting prescribing rights, you should start making plans right now.

As an example, Alberta has already secured written consent from the elected health minister that the Government of Alberta is in agreement with podiatrists having prescrib-ing privileges for controlled substances. Alberta has also had discussions with the executive of he College of Physicians and Surgeons of Alberta, the Alberta College of Pharmacists and its registrar, and the Alberta Medical Association. Each audience was provided detailed information about the qualifications and training of podiatrists practicing in Alberta, the scope of practice of these podiatrists and also the impact that the current situation has created. The discussions also included how it affects patients and the health care system in general.

We will continue to update you on this very important initiative as progress is made. In the meantime, if you have any questions, please feel free to contact me at cpmasecre-tary@podiatrycanada.org

By Dr. Richard Bochinski Chair, CPMA Narcotics CommitteeCPMA Narcotics Committee Update

Audiences that your provincial podiatry association should consider meeting with include:

• Minister of Health• Deputy Minister of

Health• College of Physicians

and Surgeons• Pharmacists Association• College of Pharmacists• Provincial Medical

Association

17

18

MARK your CALENDARand Plan to Attend …

2011 Dates

2015 DatesJuly 28-31

APMA Annual Scientific Conference Orlando, Florida www.apma.org

October 15-22

Annual Hawaii Seminar Maui, Hawaii www.nwpodiatricfoundation.org

October 26-30

ACFAOM Annual Meeting Orlando, Florida www.acfaom.org

November 11-13

International Region VII Podiatry Conference Vancouver, B.C. www.foothealth.ca or www.region7apma.org/annualmeeting.html

September 15-18

OPMA Conference Toronto, Ontario www.opma.ca 2011 CPMA AGM (date & time T.B.A.) Toronto ON www.opma.ca

CPEF AGM (date & time T.B.A.)

2014 DatesJuly 24-27

APMA Annual Scientific Conference Honolulu, Hawaii www.apma.org

2012 DatesApril 19-22

Midwest Podiatry Conference Chicago, Illinois. www.midwestpodconf.org

August 16-19

APMA Annual Scientific Conference Washington, D.C. www.apma.org

(T.B.A.)

2012 CPMA AGM Quebec www.podiatrycanada.org

2013 DatesJuly 28-31

APMA Annual Scientific Conference Boston, Massachusetts www.apma.org

September 22-24

Annual Las Vegas Scientific Seminer Las Vegas, Nevada www.newpodiatricfoundation.org July 21-25

APMA Annual Scientific Conference Las Vegas, Nevada. www.apma.org

October 3-5

FIP World Congress of Podiatry Rome, Italy. www.fipnet.org

2013 Dates

19

Client: SANOFI-AVENTISMASTERColour: Grayscale

Brand: LoproxAd No: MASTERTrim: 6" x 9.5"

S09282/2009/12/01/JRS09280 Sanofi LoproxPI Eng

Mas

ter

Patient Selection Criteria

THERAPEUTIC CLASSIFICATIONTopical Antifungal Agent

INDICATIONS AND CLINICAL USELOPROX® (ciclopirox olamine 1%) Cream or Lotion is indi cated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton fl occosum, Microsporum canis; cutaneous candidiasis (moniliasis) due to Candida albicans; and tinea (pityriasis) versicolor due to Malassezia furfur. LOPROX® is not proposed for vaginal application.

CONTRAINDICATIONSHypersensitivity to any of the components of this medication (see Dosage Forms: Composition in the Product Monograph).

SPECIAL POPULATIONSUse in pregnancy: (also see Supplemental Product Information): There are no adequate or well-controlled studies in pregnant women. This drug should be used during pregnancy only if clearly needed.Use in Nursing Mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when LOPROX® is administered to nursing women.Use in Children: Safety and effectiveness in children below the age of 10 years have not been established.

Safety Information

WARNINGSLOPROX® is not for ophthalmic use.

PRECAUTIONS If a reaction suggesting sensitivity or chemical irritation should occur with the use of LOPROX®, treatment should be discontinued and appropriate therapy instituted.

ADVERSE REACTIONSLOPROX® is well tolerated with a low incidence of adverse reactions reported in clinical trials. LOPROX® Cream had a 0.4% incidence of adverse reactions in controlled clinical trials. These included pruritus at the site of application, worsening of clinical signs and symptoms, and mild to severe burning reported in a few cases.In a controlled clinical trial with 89 patients using LOPROX® Lotion and 89 patients using the vehicle, the incidence of adverse reactions was low. The side effects included pruritus occurring in three patients and burning, which occurred in one patient.To monitor drug safety, Health Canada collects information on serious and unexpected effects of drugs. To report a serious or unexpected reaction to LOPROX®, you may notify Health Canada by toll-free telephone at 1-866-234-2345.

DOSAGE AND ADMINISTRATIONGently massage LOPROX® into the affected and surrounding skin areas twice daily, in the morning and evening for a minimum of 4 weeks. Clinical improvement with relief of pruritus and other symptoms usually occurs within the fi rst week of treatment. If a patient shows no clinical improvement after two weeks of treatment with LOPROX®, the diagnosis should be redetermined. Patients with tinea versicolor usually exhibit clinical and mycological clearing after two weeks of treatment.

1. Kligman AM, et al. Evaluation of ciclopirox olamine cream for the treatment of tinea pedis: Multicenter, double-blind comparative studies. Clin Ther 1985;7(4):409-17.Double-blind, multicentre study of 87 patients with both plantar and interdigital tinea pedis. Patients were randomized to either twice daily ciclopirox olamine 1% cream (n =43) or clotrimazole 1% cream (n =44) for four weeks.

SUPPLEMENTAL PRODUCT INFORMATION

SPECIAL POPULATIONSUse in Pregnancy: Reproduction studies have been performed in the mouse, rat, rabbit, and monkey (via various routes of administration) at doses 10 times or greater than the topical human dose. No signifi cant evidence of impaired fertility or harm to the fetus due to the use of ciclopirox olamine has been revealed. However, a higher incidence of systemic absorption of ciclopirox olamine in the rat was noted in the group given 30 mg/kg orally as compared to controls.

SYMPTOMS AND TREATMENT OF OVERDOSAGEThere have been no clinical reports of acute overdosage with LOPROX® (ciclopirox olamine) Cream or Lotion by any route of administration. From acute toxicity studies of ciclopirox olamine cream 1% in adult rats, oral doses of 36 g/kg produced no evidence of toxic signs.

DOSAGE FORMSAvailability: LOPROX® Cream is available in tubes of 45 g.LOPROX® Lotion is available in a 60 mL bottle.

Product Monograph available upon request or at www.sanofi -aventis.ca.

Copyright © 2010 sanofi -aventis. All rights reserved. sanofi -aventis Canada Inc.Laval, Quebec H7L 4A8CDN.CIC.09.11.02E

Loprox®

20

At week one,93% of Loprox® patients showed improvement in tinea pedis• Clinical response: 93% (n=43) of Loprox®

vs. 71% (n=42) of clotrimazole patients; p≤0.011†

Help your patients get antifungal relief fast

with

See prescribing summary and study parameters on page

Loprox® cream or lotion is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to T. rubrum, T. mentagrophytes, E. fl occosum, M. canis; cutaneous candidiasis (moniliasis) due to C. albicans; and tinea (pityriasis) versicolor due to M. furfur. Loprox® cream had a 0.4% incidence of adverse reactions in controlled clinical trials. These included pruritus at the site of application, worsening of clinical signs and symptoms, and mild to severe burning reported in a few cases. † Recommended dosing: minimum 4 weeks, twice daily.

Brand: MultaqAd No: XXXX Loprox J. Ad EngTrim: 8" x 10"

Client: SANOFI-AVENTIS141196 PublicationColour: 4/c process

Pub

licat

ion

141196/2009/12/18/RB141196_Loprox_Journal_Ad_Master_EN

CDN.CIC.09.12.03E

(ciclopirox olamine 1%)

19